(Q34708414)

4 August 2017

1 reference

title

The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women (English)

1 reference

4 August 2017

0 references

1 reference

Sophie Grigoriadis

1

1 reference

PubMed ID

12085678

4 August 2017

Mary V Seeman

series ordinal

2

1 reference

PubMed ID

12085678

4 August 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

Canadian Journal of Psychiatry

4 August 2017

1 reference

4 August 2017

47

1 reference

4 August 2017

5

1 reference

4 August 2017

437-442

1 reference

How does gender influence age at first hospitalization for schizophrenia? A transnational case register study

4 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Sex and Schizophrenia: Effects of Diagnostic Stringency, and Associations with Premorbid Variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Sex differences in neuroanatomical and clinical correlations in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

The epidemiology of late-onset schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Puberty and the onset of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Narratives of twenty to thirty year outcomes in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Variation in symptom severity over the menstrual cycle of schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Changes in premenstrual symptoms in women with schizophrenia: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Can estradiol modulate schizophrenic symptomatology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Epidemiology of puerperal psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Influence of the menstrual cycle phase on the therapeutic response in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Estrogen - a potential treatment for schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Estrogen receptor activation and tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Gender and the use of neuroleptics in schizophrenia. Further testing of the oestrogen hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Gender differences in schizophrenia: hormonal effect or subtypes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Regulation of progesterone receptor messenger ribonucleic acid in the rat medial preoptic nucleus by estrogenic and antiestrogenic compounds: an in situ hybridization study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Maternal endocrine activation during pregnancy alters neurobehavioral state in primate infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Treatment guidelines for psychotropic drug use in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Drug therapy for breast-feeding women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Clozapine and pulmonary embolus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Are chronic psychiatric patients at increased risk for developing breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Elevation of prolactin levels by atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

Neuroleptic-induced hyperprolactinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204700504

10.1177/070674370204700504

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12085678